Inspire MD Will Sponsor a Satellite Symposium at TCT 2010 Where new and Unprecedented Long Term Results of MGuard Multicenter Experience in Stemi Patients Will be Presented for the First Time

WASHINGTON DC, September 23, 2010 /PRNewswire/ --

- Further Exciting MGuard Clinical Findings Will be Revealed at this Year's TCT in Various Sessions Throughout the Meeting Concluding With a 'Live Case' on Saturday Morning Broadcasting MGuard Deployment from Antwerp, Belgium

InspireMD, Ltd. will reveal new clinical findings at TCT 2010. These findings include 'Long term results of MGuard Multicenter Experience in STEMI Patients' by Dr. Federico Piscione to be presented at the InspireMD Symposium as well as 'Final Results of the INSPIRE Trial with the Novel MGuard Stent for Thrombus- Containing Lesions', by Dr. Jose de Ribamar Costa Jr. and 'Six-Month Clinical and Angiographic Results of MGuard Net Protective Stent in Primary PCI' by Dr. Dezso Apro presented at the Poster Session on Wednesday September 22nd.

On Thursday 23/9, at 2:36 pm, Dr. Chaim Lotan will present "Improving Microcirculatory Function - A Covered Stent for STEMI- Increasing Experience with MGuard" as part of the Emerging Drugs and Devices for STEMI and NSTEMI in Room 151AB.

InspireMD's Satellite Symposium will take place Friday, September 24th at 10-11am in the Presentation Theater and will be chaired by Drs. Alexandra J. Lansky,and Roxana Mehran. The session titled "MGuard Embolic Protection Stent: Novel Primary PCI Solutions and Challenging Cases" will reveal new, unprecedented clinical findings of long term MGuard Multicenter Experience in STEMI patients as well as important insights into the MGuard MicroNet(R) Mesh Technology and presentation and discussion of recent challenging MGuard PPCI cases. The meeting faculty includes the distinguished Drs. Alexandre Abizaid, Dezso Apro, Dariusz Dudek, Michael Gibson, Chaim Lotan, Federico Piscione, and Sigmund Silber.

Also on Friday 24/9, at 12:15pm, Dr. Dariusz Dudek will present a challenging MGuard case in the session "Acute Infarct Angioplasty and the Thrombus-Containing Lesion I" taking place in Room 143A.

A 'Live Case' broadcast of MGuard Deployment with Dr. Glenn Van Langenhove from Antwerp, Belgium will take place on Saturday 25/9 at 9:15 am at Lower Level.

Finally, don't forget to visit InspireMD's booth #2052 to learn about MGuard Prime, InspireMD's new Cobalt Chromium Net Protective Stent System. MGuard Prime presents an advanced Co-Cr Design with superior flexibility, excellent deliverability and InspireMD's unique MicroNet(R) Mesh Technology. MGuard Prime is indicated for Primary PCI for STEMI, Saphenous Vein Grafts and ACS with visible thrombus. The new MGuard PRIME is CE Marked and will be available in 2011 in selected territories.

About MGuard(TM) Coronary

MGuard(TM) presents a novel combination of a coronary stent merged with an embolic protection specifically designed for Acute MI patients. The embolic protection is comprised of an ultra-thin polymer mesh sleeve that wraps the stent. The MGuard(TM) coronary stent provides permanent embolic protection, without affecting deliverability. MGuard(TM) is CE Mark approved. The MGuard(TM) Coronary's innovative concept has enjoyed an enthusiastic welcome from leading interventional cardiologists around the world.

About InspireMD

InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD's mission is to utilize its proprietary technology to make its products the industry standard for stents and to provide a superior solution to the key clinical issues of current stenting: restenosis, embolic showers, and late thrombosis. In addition to providing embolic protection and minimizing arterial injury, this promising technology can be an effective and uniform drug delivery mechanism with the help of the novel micron-level net for next generation drug eluting stents. InspireMD intends to pursue applications of this technology both for bare metal and drug eluting stents in coronary, carotid and peripheral artery procedures.

    Contact details:

    http://www.inspire-md.com

    Jonina Ohayon
    Marketing Director
    Tel +972-52-5791120
    [email protected]

SOURCE InspireMD